Valuation: OrganiGram Holdings Inc

Market Cap 20Cr 14Cr 13Cr 12Cr 11Cr 1.37TCr 21Cr 138.62Cr 54Cr 672.18Cr 54Cr 53Cr 2.33TCr P/E 2026 *
11.2x
P/E 2027 * 36.3x
Enterprise Value 20Cr 14Cr 13Cr 12Cr 11Cr 1.37TCr 21Cr 138.62Cr 54Cr 672.18Cr 54Cr 53Cr 2.33TCr EV / Sales 2026 *
0.6x
EV / Sales 2027 * 0.46x
Free-Float
69.76%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 15/01/2026
Director of Finance/CFO - 08/01/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 65 29/03/2018
Director/Board Member 56 17/12/2018
Director/Board Member 70 17/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
+4.72%+2.95% - - 14Cr
+1.03%+4.23%+55.12%+214.09% 22Cr
+1.09%+8.82%+18.59%+101.09% 13Cr
-6.36%-9.20%+39.19%-0.82% 9.28Cr
-3.57%-1.07%-38.86%-45.57% 5.93Cr
Average -0.62%+3.56%+18.51%+67.20% 12.56Cr
Weighted average by Cap. +0.38%+4.62%+31.83%+115.09%

Financials

2026 *2027 *
Net sales 34Cr 24Cr 21Cr 19Cr 18Cr 2.28TCr 34Cr 230.6Cr 90Cr 1.12TCr 90Cr 88Cr 3.88TCr 44Cr 31Cr 27Cr 25Cr 23Cr 2.96TCr 45Cr 299.36Cr 116.5Cr 1.45TCr 116.43Cr 113.87Cr 5.03TCr
Net income 1.89Cr 1.33Cr 1.16Cr 1.07Cr 99.41L 126.64Cr 1.91Cr 13Cr 4.99Cr 62Cr 4.99Cr 4.88Cr 215.52Cr 65.3L 45.93L 40.22L 37.05L 34.39L 44Cr 66.19L 4.43Cr 1.73Cr 22Cr 1.72Cr 1.69Cr 75Cr
Net Debt - -
Logo OrganiGram Holdings Inc
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-